Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1996-12-10
2000-03-28
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514912, A61K 31555
Patent
active
060432373
ABSTRACT:
Photodynamic therapy to prevent secondary cataracts is effected using photosensitizers such as green porphyrins as photoactive agents to destroy remnant lens epithelial cells.
REFERENCES:
patent: 4920143 (1990-04-01), Levy et al.
patent: 5095030 (1992-03-01), Levy et al.
patent: 5171749 (1992-12-01), Levy et al.
patent: 5202252 (1993-04-01), Emery et al.
patent: 5273751 (1993-12-01), Dubroff
patent: 5375611 (1994-12-01), Lindqvist et al.
patent: 5399583 (1995-03-01), Levy et al.
patent: 5401880 (1995-03-01), Clark et al.
patent: 5445637 (1995-08-01), Bretton
patent: 5798349 (1998-08-01), Levy et al.
Apple, D. J. et al., "Posterior Capsule Opacification," Survey of Ophthalmology, 37(2):73(1992).
Haimovici, R. et al. "Localization of Benzoporphyrin Derivative Monoacid in the Rabbit Eye," IOVS 34:1303 as Abstracts 2955 (1993).
Kappelhoff, J.P., et al., "The Pathology of After-Cataract. A Mini Review, " Acta Opthalmol. Suppl. 205:13 (1992).
Lin, C.P. et al. IOVS 34:1168 Abstract 2293 (1993).
Lin , S.C. et al. IOVS 34:1303 Abstract 2953 (1993).
Lindquist, B., et al., "Method for Preventing Secondary Cataract, " U.S. Patent No. 5,375,611 (1994).
Linfgua, R. et al., "Preclinical Evaluation of Photodynamic Therapy to Inhibit Lens Epithelial Proliferation," Lasers and Light in Ophthalmology 2(2):103 (1988).
Lundgren, B., et al., "Secondary Cataract: An In vivo Model for Studies on Secondary Cataract in Rabbits," Acta Opthalmol. Suppl. 205:25 (1992).
Moulton, R.S. et al. "Response of Retinal and Choroidal Vessels to Photodynamic Therapy Using Benzoporphyrin Derivative Monoacid", IOVS 34:1169 Abstract 58 (1993).
Nishi, O. et al., "Intercapsular Cataract Surgery with Lens Epithelial Cell Removal," J. Cataract Refract. Surg. 17:471-477 (1991).
Parel, J.M. et al., "Endocapsular Lavage with Photofrin II as a Photodynamic Therapy for Lens Epithelial Proliferation," Lasers and Medical Science 5:25 (1990).
Schmidt, U. et al. Photosensitizing Potency of Benzoporphyrin Derivative (BPD) Assiociated with Human Low Density Lipoprotein (LDL). IOVS 33:1253 Abstract 2802 (1992).
Schmidt-Erfurth, U. et al. "Photothrombosis of Ocular Neovascularization Using BPD, " IOVS 34:1303 as Abstracts 2956 (1993).
Walsh, A.W. et al. Photodynamic Therapy of Experimental Choroidal Neovascularizatioin Using BPD-MA, IOVS 34:1303 as Abstracts 2954 (1993).
Wunderlich, K. et al., "Photodynamic Activity of Phthalocyanines in Cultivated Lens Epithelial Cells of the Pig," Ophthalmology 92(3):346 (1995).
Xia, X.P., et al. "A Cytological Study of Inhibition of Secondary Cataract with Heparin," Chung Hua Yen Ko Tsa Chih, 30(5):363 (1994).
Xia, X.P., et al. "A Clinical Study of Inhibition of Secondary Cataract with Heparin,"Chung Hua Yen Ko Tsa Chih, 30(6):405 (1994).
Li, KF, et al., "514.5nm DHE-PDT and Lens Epithelial Proliferation in vitro: A Pilot Study,"Photochem. Photobiol., 51 (Suppl.) Abstract 75s (1990).
Parel, J-M, et al., "Preclinical Evaluation of Photodynamic Therapy To Retard Lens Epithelial Proliferation After Endocapsular Lensectomy, " Invest Ophthalmo. Visual Sci., 28(3):89 (1987).
Bussanich Marcello Nick
Hariton Claude A. A.
Huber Gustav
Levy Julia G.
Mallek David R.
Ciba Vision Opthalmics
Fay Zohreh
QLT PhotoTherapeutics, Inc.
The University of the British of Columbia
LandOfFree
Use of photodynamic therapy for prevention of secondary cataract does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of photodynamic therapy for prevention of secondary cataract, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of photodynamic therapy for prevention of secondary cataract will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1326219